Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit anti-AHCY Polyclonal Antibody
| Applications | ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human AHCY |
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-TUBB(beta Tubulin) antibody, Loading control
| Applications | WB |
| Reactivities | Human, Mouse, Chicken, Xenopus, Porcine, Zebrafish, Hamster, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to the N-terminal region of human beta tubulin (within residues 1-100). Swiss-Prot P07437. |
Rabbit polyclonal IRS-1 (Ab-312) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human IRS-1 around the phosphorylation site of serine 312 (A-T-SP-P-A). |
Rabbit Anti-NMDA NR2B Subunit Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein from the C-terminal region of the NR2B subunit |
Rabbit Polyclonal Anti-NOTCH2 (Cleaved-Ala1734) Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-NOTCH2 (Cleaved-Ala1734) Antibody: A synthesized peptide derived from human NOTCH2 (Cleaved-Ala1734) |
Rabbit Polyclonal antibody to GAD65 (glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa))
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 353 and 585 of GAD65 (Uniprot ID#Q05329) |
Rabbit polyclonal IRF-3 (Ser385) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRF-3 around the phosphorylation site of serine 385 (G-A-SP-S-L). |
| Modifications | Phospho-specific |
Rabbit polyclonal eNOS (Thr495) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human eNOS around the phosphorylation site of threonine 495 (K-K-TP-F-K). |
| Modifications | Phospho-specific |
Rabbit anti-STAT3 (Phospho-Tyr705) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Syndecan4 (Ab-179) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Syndecan4 around the phosphorylation site of serine 179 (E-G-SP-Y-D). |
Rabbit Polyclonal antibody to RAC1 (ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1))
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 1 and 196 of RAC1 (Uniprot ID#P63000 isoform B) |
Rabbit polyclonal anti-DSG1 antibody
| Applications | WB |
| Reactivities | Human Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human DSG1. |
Rabbit polyclonal Neuro D (Ser274) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Neuro D around the phosphorylation site of serine 274 (P-L-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal SNAI1 (Ser246) antibody(Phospho-specific)
| Applications | IF, WB |
| Reactivities | Human: Ser246, Mouse: Ser246 |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human SNAI1 around the phosphorylation site of serine 246 (T-F-SP-R-M). |
| Modifications | Phospho-specific |
Rabbit polyclonal GR (Ab-211) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GR around the phosphorylation site of serine 211 (N-E-S-P-W). |
Rabbit polyclonal MITF (Ab-180/73) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human MITF around the phosphorylation site of serine 180/73 (P-N-SP-P-M). |
Anti-RAC2 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 50-192 amino acids of human ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
Rabbit Polyclonal CD44 (Ser706) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CD44 around the phosphorylation site of Serine 706 |
| Modifications | Phospho-specific |
Rabbit Polyclonal CrkII (Tyr221) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human CrkII around the phosphorylation site of Tyrosine 221 |
| Modifications | Phospho-specific |
Rabbit polyclonal GRB2 (Ab-159) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GRB2 around the phosphorylation site of serine 159 (K-S-SP-A-P). |
Active filters
Category
- Antibodies
Reactivities
- Mouse
Applications
- WB
Antibody Hosts
- Rabbit
Isotypes
- IgG
Conjugates
- Unconjugated
Families
- Druggable Genome
Citations
- Yes
Availabilities
- In Stock
Filter by
Target Symbol
- BAX (2)
- IRS1 (2)
- STAT5A (2)
- ABCD2 (1)
- ABCD3 (1)
- AGL (1)
- AHCY (1)
- AICDA (1)
- ANPEP (1)
- ANTXR1 (1)
- AOX1 (1)
- BAG3 (1)
- BID (1)
- BRAF (1)
- CCNA2 (1)
- CCNE1 (1)
- CD44 (1)
- CDK6 (1)
- CDKN1A (1)
- CENPE (1)
- CRK (1)
- CTNNB1 (1)
- CTSA (1)
- CYP19A1 (1)
- CYP3A4 (1)
- DSG1 (1)
- EXT1 (1)
- FZD2 (1)
- GAB2 (1)
- GAD1 (1)
- GAD2 (1)
- GPD2 (1)
- GRIN2B (1)
- HSP90AA1 (1)
- IRF3 (1)
- ITGA4 (1)
- JAK1 (1)
- JAK2 (1)
- KDR (1)
- KLK5 (1)
- LIMK1 (1)
- MAP3K5 (1)
- MAPK3 (1)
- MDM2 (1)
- MITF (1)
- MMP2 (1)
- MSH6 (1)
- MYCN (1)
- NEK2 (1)
- NEUROD1 (1)
- NOS3 (1)
- NOTCH1 (1)
- NOTCH2 (1)
- NR3C1 (1)
- NR4A3 (1)
- NTRK2 (1)
- OAT (1)
- OPN3 (1)
- PAK1 (1)
- PAK2 (1)
- PAK5 (1)
- PFKFB2 (1)
- PLK3 (1)
- POFUT1 (1)
- PPARGC1A (1)
- PRKAR1A (1)
- PTEN (1)
- RAC1 (1)
- RAC2 (1)
- RBM5 (1)
- RELA (1)
- ROCK1 (1)
- SDC4 (1)
- SLC2A1 (1)
- SNAI1 (1)
- SNAP23 (1)
- SOD2 (1)
- SPP1 (1)
- STAT3 (1)
- TNFRSF10D (1)
- TP53INP1 (1)
- TRAF3IP1 (1)
- TRPC6 (1)
- TUBB (1)
- TUBB3 (1)
- ZEB2 (1)
Clonalities
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (26)
- Focal adhesion (14)
- Metabolic pathways (11)
- Neurotrophin signaling pathway (11)
- Regulation of actin cytoskeleton (11)
- Chemokine signaling pathway (10)
- Chronic myeloid leukemia (10)
- MAPK signaling pathway (10)
- Colorectal cancer (9)
- ErbB signaling pathway (9)
- Prostate cancer (9)
- Axon guidance (8)
- Pancreatic cancer (8)
- Renal cell carcinoma (8)
- p53 signaling pathway (8)
- Adipocytokine signaling pathway (7)
- Amyotrophic lateral sclerosis (ALS) (7)
- Fc gamma R-mediated phagocytosis (7)
- Insulin signaling pathway (7)
- Melanoma (7)
- Natural killer cell mediated cytotoxicity (7)
- Acute myeloid leukemia (6)
- Apoptosis (6)
- Glioma (6)
- Leukocyte transendothelial migration (6)
- Adherens junction (5)
- Bladder cancer (5)
- Cell cycle (5)
- Huntington's disease (5)
- Jak-STAT signaling pathway (5)
- Small cell lung cancer (5)
- T cell receptor signaling pathway (5)
- Toll-like receptor signaling pathway (5)
- VEGF signaling pathway (5)
- Wnt signaling pathway (5)
- Alzheimer's disease (4)
- B cell receptor signaling pathway (4)
- ECM-receptor interaction (4)
- Endometrial cancer (4)
- Fc epsilon RI signaling pathway (4)
- Melanogenesis (4)
- Pathogenic Escherichia coli infection (4)
- Prion diseases (4)
- Progesterone-mediated oocyte maturation (4)
- Dorso-ventral axis formation (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Gap junction (3)
- Hematopoietic cell lineage (3)
- Long-term depression (3)
- Long-term potentiation (3)
- NOD-like receptor signaling pathway (3)
- Non-small cell lung cancer (3)
- Thyroid cancer (3)
- Type II diabetes mellitus (3)
- Vascular smooth muscle contraction (3)
- Viral myocarditis (3)
- ABC transporters (2)
- Alanine (2)
- Arginine and proline metabolism (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Basal cell carcinoma (2)
- Butanoate metabolism (2)
- Cell adhesion molecules (CAMs) (2)
- Cytokine-cytokine receptor interaction (2)
- Cytosolic DNA-sensing pathway (2)
- Drug metabolism - cytochrome P450 (2)
- Endocytosis (2)
- GnRH signaling pathway (2)
- Neuroactive ligand-receptor interaction (2)
- Notch signaling pathway (2)
- Oocyte meiosis (2)
- RIG-I-like receptor signaling pathway (2)
- Renin-angiotensin system (2)
- TGF-beta signaling pathway (2)
- Taurine and hypotaurine metabolism (2)
- Tight junction (2)
- Type I diabetes mellitus (2)
- aspartate and glutamate metabolism (2)
- beta-Alanine metabolism (2)
- mTOR signaling pathway (2)
- Androgen and estrogen metabolism (1)
- Antigen processing and presentation (1)
- Calcium signaling pathway (1)
- Cysteine and methionine metabolism (1)
- Dilated cardiomyopathy (1)
- Drug metabolism - other enzymes (1)
- Fructose and mannose metabolism (1)
- Glutathione metabolism (1)
- Glycerophospholipid metabolism (1)
- Heparan sulfate biosynthesis (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Inositol phosphate metabolism (1)
- Linoleic acid metabolism (1)
- Maturity onset diabetes of the young (1)
- Metabolism of xenobiotics by cytochrome P450 (1)
- Mismatch repair (1)
- Nicotinate and nicotinamide metabolism (1)
- Phosphatidylinositol signaling system (1)
- Primary immunodeficiency (1)
- Retinol metabolism (1)
- SNARE interactions in vesicular transport (1)
- Selenoamino acid metabolism (1)
- Starch and sucrose metabolism (1)
- Systemic lupus erythematosus (1)
- Tryptophan metabolism (1)
- Tyrosine metabolism (1)
- Ubiquitin mediated proteolysis (1)
- Valine (1)
- Vitamin B6 metabolism (1)
- leucine and isoleucine degradation (1)